Quick Heal Technologies Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Quick Heal Technologies için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Software kazanç büyümesi	15.8%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Quick Heal Technologies Limited (NSE:QUICKHEAL) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Nov 13

Impressive Earnings May Not Tell The Whole Story For Quick Heal Technologies (NSE:QUICKHEAL)

Oct 25

Revenues Not Telling The Story For Quick Heal Technologies Limited (NSE:QUICKHEAL) After Shares Rise 27%

Sep 05

Quick Heal Technologies' (NSE:QUICKHEAL) Returns On Capital Tell Us There Is Reason To Feel Uneasy

Jul 23

Revenues Not Telling The Story For Quick Heal Technologies Limited (NSE:QUICKHEAL) After Shares Rise 26%

Jul 05

Quick Heal Technologies Limited's (NSE:QUICKHEAL) Share Price Not Quite Adding Up

Jan 17

Quick Heal Technologies (NSE:QUICKHEAL) Is Paying Out Less In Dividends Than Last Year

Jul 23

Quick Heal Technologies' (NSE:QUICKHEAL) Returns On Capital Not Reflecting Well On The Business

Apr 06

We Like These Underlying Return On Capital Trends At Quick Heal Technologies (NSE:QUICKHEAL)

Jan 26

Most Shareholders Will Probably Agree With Quick Heal Technologies Limited's (NSE:QUICKHEAL) CEO Compensation

Jul 30

Investors Will Want Quick Heal Technologies' (NSE:QUICKHEAL) Growth In ROCE To Persist

May 31

Does Quick Heal Technologies' (NSE:QUICKHEAL) CEO Salary Compare Well With The Performance Of The Company?

Feb 17

Are Quick Heal Technologies Limited's (NSE:QUICKHEAL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Feb 04

Should We Be Excited About The Trends Of Returns At Quick Heal Technologies (NSE:QUICKHEAL)?

Jan 17

If You Had Bought Quick Heal Technologies' (NSE:QUICKHEAL) Shares Three Years Ago You Would Be Down 49%

Dec 28

What Type Of Shareholders Make Up Quick Heal Technologies Limited's (NSE:QUICKHEAL) Share Registry?

Dec 10

Need To Know: Quick Heal Technologies Limited (NSE:QUICKHEAL) Insiders Have Been Selling Shares

Nov 22

Key Things To Watch Out For If You Are After Quick Heal Technologies Limited's (NSE:QUICKHEAL) 2.5% Dividend

Nov 02

Will Quick Heal Technologies (NSE:QUICKHEAL) Multiply In Value Going Forward?

Oct 15

Reflecting on Quick Heal Technologies' (NSE:QUICKHEAL) Share Price Returns Over The Last Three Years

Sep 28

Is Quick Heal Technologies Limited's (NSE:QUICKHEAL) Latest Stock Performance A Reflection Of Its Financial Health?

Sep 07

A Look At The Fair Value Of Quick Heal Technologies Limited (NSE:QUICKHEAL)

Aug 20

It's A Story Of Risk Vs Reward With Quick Heal Technologies Limited (NSE:QUICKHEAL)

Aug 05

Could The Quick Heal Technologies Limited (NSE:QUICKHEAL) Ownership Structure Tell Us Something Useful?

Jul 21

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Quick Heal Technologies yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

NSEI:QUICKHEAL - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	3,057	323	-133	-35	N/A
6/30/2024	3,106	410	N/A	N/A	N/A
3/31/2024	2,918	242	106	182	N/A
12/31/2023	2,610	36	N/A	N/A	N/A
9/30/2023	2,459	-158	194	270	N/A
6/30/2023	2,685	-65	N/A	N/A	N/A
3/31/2023	2,781	64	267	308	N/A
12/31/2022	3,325	411	N/A	N/A	N/A
9/30/2022	3,454	647	337	399	N/A
6/30/2022	3,482	772	N/A	N/A	N/A
3/31/2022	3,419	832	741	800	N/A
12/31/2021	3,435	948	N/A	N/A	N/A
9/30/2021	3,337	940	808	914	N/A
6/30/2021	3,144	882	N/A	N/A	N/A
3/31/2021	3,330	1,070	898	986	N/A
12/31/2020	2,920	752	N/A	N/A	N/A
9/30/2020	2,878	796	662	751	N/A
6/30/2020	3,020	875	N/A	N/A	N/A
3/31/2020	2,861	744	592	706	N/A
12/31/2019	3,079	942	N/A	N/A	N/A
9/30/2019	3,089	922	548	673	N/A
6/30/2019	3,194	976	N/A	N/A	N/A
3/31/2019	3,149	918	505	614	N/A
12/31/2018	3,476	1,133	N/A	N/A	N/A
9/30/2018	3,452	1,041	N/A	N/A	N/A
6/30/2018	3,411	1,004	N/A	N/A	N/A
3/31/2018	3,183	830	N/A	939	N/A
12/31/2017	2,907	560	N/A	N/A	N/A
9/30/2017	2,810	472	N/A	N/A	N/A
6/30/2017	2,827	474	N/A	N/A	N/A
3/31/2017	3,000	532	N/A	358	N/A
12/31/2016	3,572	680	N/A	N/A	N/A
9/30/2016	3,581	634	N/A	N/A	N/A
6/30/2016	3,371	525	N/A	N/A	N/A
3/31/2016	3,021	579	N/A	777	N/A
3/31/2015	2,861	538	N/A	772	N/A
3/31/2014	2,428	584	N/A	607	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: QUICKHEAL 'un tahmini kazanç büyümesinin tasarruf oranının ( 6.7% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: QUICKHEAL 'un kazançlarının Indian pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: QUICKHEAL şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: QUICKHEAL şirketinin gelirinin Indian pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: QUICKHEAL şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: QUICKHEAL 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Quick Heal Technologies Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

New major risk - Share price stability

Quick Heal Technologies Limited (NSE:QUICKHEAL) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Impressive Earnings May Not Tell The Whole Story For Quick Heal Technologies (NSE:QUICKHEAL)

Second quarter 2025 earnings released: EPS: ₹0.77 (vs ₹2.43 in 2Q 2024)

Quick Heal Technologies Limited to Report Q2, 2025 Results on Oct 17, 2024

Quick Heal Technologies Limited Announces the Launch of India's First Fraud Prevention Solution - AntiFraud.AI

Insufficient new directors

Quick Heal Technologies Limited Appoints Kamal Kumar Agarwal as an Independent Director

Revenues Not Telling The Story For Quick Heal Technologies Limited (NSE:QUICKHEAL) After Shares Rise 27%

Upcoming dividend of ₹3.00 per share

Quick Heal Technologies Limited, Annual General Meeting, Sep 06, 2024

First quarter 2025 earnings released: EPS: ₹0.75 (vs ₹2.40 loss in 1Q 2024)

Quick Heal Technologies' (NSE:QUICKHEAL) Returns On Capital Tell Us There Is Reason To Feel Uneasy

Quick Heal Technologies Limited to Report Q1, 2025 Results on Jul 26, 2024

Revenues Not Telling The Story For Quick Heal Technologies Limited (NSE:QUICKHEAL) After Shares Rise 26%

Full year 2024 earnings released: EPS: ₹4.56 (vs ₹1.14 in FY 2023)

Quick Heal Technologies Limited Recommends Final Dividend for the Year 2023-24

Quick Heal Technologies Limited to Report Q4, 2024 Results on Apr 25, 2024

Head of Retail Sales recently sold ₹1.1m worth of stock

Head of Retail Sales recently sold ₹3.5m worth of stock

Quick Heal Technologies Limited Announces Appointment of Dr. Lalit Mohan Sanagavarapu as Chief Product Officer

Third quarter 2024 earnings released: EPS: ₹1.89 (vs ₹1.70 loss in 3Q 2023)

Quick Heal Technologies Limited's (NSE:QUICKHEAL) Share Price Not Quite Adding Up

Quick Heal Technologies Limited to Report Q2, 2024 Results on Jan 24, 2024

Chief Product Officer recently sold ₹29m worth of stock

Second quarter 2024 earnings released: EPS: ₹2.43 (vs ₹3.82 in 2Q 2023)

Quick Heal Technologies Limited Appoints Sarang Deshpande as Company Secretary and Compliance Officer

Quick Heal Technologies Limited Announces the Resignation of Vinav Agarwal as Compliance Officer, Effective September 15, 2023

Insufficient new directors

New minor risk - Share price stability

Quick Heal Technologies (NSE:QUICKHEAL) Is Paying Out Less In Dividends Than Last Year

Quick Heal Technologies Limited Proposes Final Dividend for the Financial Year Ended March 31, 2023

New minor risk - Market cap size

First quarter 2024 earnings released: ₹2.40 loss per share (vs ₹0.03 profit in 1Q 2023)

Quick Heal Technologies Limited Announces Resignation of Srinivasa Rao as Company Secretary & Key Managerial Person

Quick Heal Technologies Limited to Report Q1, 2024 Results on Jul 20, 2023

Quick Heal Technologies Limited Announces Management Changes

Full year 2023 earnings released: EPS: ₹1.14 (vs ₹14.01 in FY 2022)

Quick Heal Technologies' (NSE:QUICKHEAL) Returns On Capital Not Reflecting Well On The Business

Third quarter 2023 earnings released: ₹1.70 loss per share (vs ₹2.47 profit in 3Q 2022)

Quick Heal Technologies Limited to Report Q3, 2023 Results on Jan 24, 2023

Quick Heal Technologies Limited Announces Resignation of Mehul Savla as Independent Director

Second quarter 2023 earnings released: EPS: ₹3.82 (vs ₹5.39 in 2Q 2022)

Now 21% undervalued

Insider recently sold ₹4.4m worth of stock

Upcoming dividend of ₹4.50 per share

Quick Heal Technologies Limited, Annual General Meeting, Aug 26, 2022

Quick Heal Technologies Limited Proposes Dividend for Year Ended March 31, 2022

Quick Heal Technologies Limited (BSE:539678) announces an Equity Buyback for 5,000,000 shares, for INR 1,500 million.

First quarter 2023 earnings released: EPS: ₹0.03 (vs ₹0.97 in 1Q 2022)

Investor sentiment improved over the past week

Quick Heal Technologies Limited to Report Q1, 2022 Results on Jul 21, 2022

Quick Heal Technologies Limited Announces Senior Management Changes

Head of Research & Development recently sold ₹2.9m worth of stock

Quick Heal Technologies Limited Recommends Final Dividend for the Year 2021-2022

Full year 2022 earnings released: EPS: ₹14.01 (vs ₹16.66 in FY 2021)

Head of Research & Development recently sold ₹1.0m worth of stock

We Like These Underlying Return On Capital Trends At Quick Heal Technologies (NSE:QUICKHEAL)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Insider recently sold ₹9.7m worth of stock

Investor sentiment deteriorated over the past week

Most Shareholders Will Probably Agree With Quick Heal Technologies Limited's (NSE:QUICKHEAL) CEO Compensation

Upcoming dividend of ₹4.00 per share

Full year 2021 earnings released: EPS ₹16.66 (vs ₹11.34 in FY 2020)

Insider recently sold ₹1.6m worth of stock

Investors Will Want Quick Heal Technologies' (NSE:QUICKHEAL) Growth In ROCE To Persist

Investor sentiment improved over the past week

Quick Heal Technologies Limited Recommends Final Dividend for the Year 2020-21

Full year 2021 earnings released: EPS ₹16.66 (vs ₹11.34 in FY 2020)

Investor sentiment improved over the past week

New 90-day high: ₹181

Does Quick Heal Technologies' (NSE:QUICKHEAL) CEO Salary Compare Well With The Performance Of The Company?

Third quarter 2021 earnings released: EPS ₹2.10 (vs ₹2.77 in 3Q 2020)

Are Quick Heal Technologies Limited's (NSE:QUICKHEAL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Should We Be Excited About The Trends Of Returns At Quick Heal Technologies (NSE:QUICKHEAL)?